Hearsay is that Al Mann, CEO of MannKind Corp., is one of those people who’s either brilliant, crazy, or a combination thereof. Probably the latter. And I guess you’d have to be to keep pushing ahead on developing a powdered inhalable insulin product in the wake of Pfizer’s colossal flop Exubera.
I interviewed Al Mann last November (when their product Afrezza was still spelled with an ‘s’). I thought his claims about this new mealtime…
Read more »
You heard of Medingo, right? The Israeli start-up company whose new patch pump technology was recently acquired by Accu-Chek/Roche Diabetes?
Well, there’s another Israeli start-up that’s presumably hoping to beat a similar path. The company is called NiliMedix, based in the country’s Haifa District. They’re developing both “advanced insulin pump technology” — a supposedly smaller, lighter and more sophisticated pump than any on the market today — and also “innovative measures for the most accurate…
Read more »
It’s been a whirlwind few days here at the 2009 American Diabetes Association annual conference in New Orleans. Consider:
389 oral presentations
100 clinical symposia (more science talks)
104 late-breaking abstracts (papers submitted after the conference program was filled up)
1,538 research posters
465 published abstracts (research synopses)
150+ exhibitors on one enormous exposition floor
In short, it’s been factual overload — beginning with the first thing I learned this weekend: I didn’t even know…
Read more »
It’s Sunday morning, and as predicted, my feet hurt already. Been so busy running around the halls of the Ernest N. Morial Convention Center here in New Orleans, meeting D-folk and soaking up as much info as possible, that I haven’t had much time to post yet. Been twittering intermittently, though. Catch up my updates there.
For the big news, see the myriad MSM headlines about the RECORD study results, a controversial trial showing that…
Read more »
Today kicks off the American Diabetes Association’s 2009 annual conference, this year in balmy New Orleans. I won’t be responding to emails today, because I’m underway!
It’s actually a nostalgic day for me, because my decision to attend the ADA conference taking place in San Diego four years ago was a milestone — being there amongst the diabetes A-list and seeing all the reams of information, excitement and fanfare around new treatments and products changed my…
Read more »
